As expected, portal pressure of the liver cirrhosis group was higher than that of the control group significantly, and external administration of IGF-1 reduced portal pressure of the liver cirrhotic rats (Fig. 3a), which showed that IGF-1 was a negative regulating factor in portal hypertension of liver cirrhosis. Here, IGF1 is linked to portal hypertension.